František Tylš
Psychopharmacologist
Data updated
Papers
Trials
Research Footprint
František Tylš appears in 12 tracked papers (2012–2026), most studied alongside Psilocybin, Placebo and 2C-X, across Healthy Volunteers, Neuroimaging & Brain Measures and Depressive Disorders.
Most-cited paper: Psilocybin - Summary of knowledge and new perspectives (263 citations).
Frequent co-authors: Tomáš Páleníček, Martin Brunovský and Michaela Viktorinová.
Background & Research
František Tylš is a psychopharmacologist whose recent work focuses on the behavioural and neurophysiological effects of psilocybin and its active metabolite psilocin across species. His body of work spans controlled studies in healthy human volunteers (including event-related potentials such as P300 and mismatch negativity, declarative memory consolidation, and sleep measures) and preclinical investigations addressing sensory and sex-dependent behavioural responses in rodents.
Tylš's contributions are characterised by a translational approach that integrates EEG-based cognitive electrophysiology, sleep research, and animal behavioural pharmacology to elucidate how serotonergic psychedelics alter sensory processing, higher-order cognition, and sleep architecture—areas with direct relevance to proposed antidepressant mechanisms and the neurobiology of altered perception. His publications include cross-species demonstrations of psilocin-induced visual distortions and investigations into how daytime psilocybin administration affects sleep and memory consolidation.
Key Impact
Notable for translational research on psilocybin and psilocin that links preclinical models with human electrophysiology and sleep-related mechanisms relevant to therapeutic action.
Collaboration Network
8 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations František Tylš is associated with.